Network pharmacology analysis of Giant Knotweed Rhizome in sleep disorders
Integrate Medicine · 31.01.2026
DOI: 10.61958/imru8157 ↗Kurz gefasst
Fachartikel in der Zeitschrift Integrate Medicine, online erschienen am 31.01.2026. Verfasst von Shu Ren und 2 weiteren Autor:innen. Die Arbeit nennt 57 Literaturangaben.
Abstract (Originalsprache)
Background
Sleep disorders affect approximately 10–20% of the global population and are associated with reduced quality of life as well as increased risks of anxiety and depression. Polygonum cuspidatum (Giant Knotweed) has been reported to possess anti-inflammatory and neuroprotective activities, but its potential mechanisms in the treatment of sleep disorders remain unclear.
Methods
Potential targets related to sleep disorders and Giant Knotweed were retrieved from the GeneCards and HERB databases. Intersecting targets were identified using a Venn diagram. A protein–protein interaction (PPI) network was constructed using the STRING database and analyzed with Cytoscape to identify hub genes based on the maximal clique centrality (MCC) algorithm. Gene Ontology (GO) functional annotation and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analyses were performed using the Metascape platform.
Results
A total of 1,915 targets related to sleep disorders and 344 targets related to Giant Knotweed were identified, among which 162 overlapping genes were obtained. Network analysis identified ten hub genes, including STAT3, JUN, IL6, TNF, HIF1A, AKT1, MMP9, IL1B, CASP3, and INS. Enrichment analysis suggested that these genes were mainly involved in biological processes associated with neuroinflammation, synaptic structure regulation, and kinase activity. Several signaling pathways related to sleep regulation were significantly enriched, including neuroactive ligand–receptor interaction, IL-17 signaling, and PI3K–Akt signaling pathways.
Conclusion
Giant Knotweed may improve sleep disorders through multi-target and multi-pathway regulation involving inflammatory responses, neuronal protection, metabolic regulation, and synaptic remodeling. These findings provide a molecular basis for further investigation of Giant Knotweed as a potential therapeutic strategy for sleep disorders.
Zitieren
APA
Ren, S., Shou, Y., & Liao, Y. (2026). Network pharmacology analysis of Giant Knotweed Rhizome in sleep disorders. Integrate Medicine. https://doi.org/10.61958/imru8157
Vancouver
Ren S, Shou Y, Liao Y. Network pharmacology analysis of Giant Knotweed Rhizome in sleep disorders. Integrate Medicine. 2026. doi:10.61958/imru8157
BibTeX
@article{Ren2026,
author = {Ren, Shu and Shou, Ya-Ling and Liao, Yu-Feng},
title = {Network pharmacology analysis of Giant Knotweed Rhizome in sleep disorders},
journal = {Integrate Medicine},
year = {2026},
doi = {10.61958/imru8157}
}
EUVIMED